best glp 1 for dementia Frontiers GLP-1 Drugs and Brain Health:

Explore the latest insights on access, mental health, and off-label use in T1D.

Healthier insulin response

Learn the metabolic reasons, trial data, and evidence-based next steps.

Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors can reduce CV risk in patients with T2D, and both are recommended by the American Diabetes Association to reduce the risk of major cardiovascular events (MACE)

The Just Thrive Promise We are passionate about empowering your health journey through foundational gut support

A new study uncovered an association between glucagon-like peptide-1 receptor agonist (GLP-1RAs) use and an increased risk of gastroparesis (GP) among patients with Type 2 diabetes.